The US share of global life sciences venture capital rose to 67% in Q4 2024, up from 59% in 2023.
CRE Herald
Unlock Unlimited CRE Intelligence
Access in-depth market analysis, investment insights and exclusive commercial real estate coverage.
Already a subscriber? Log in













